Adagene Inc (ADAG)
2.14
-0.17
(-7.36%)
USD |
NASDAQ |
May 07, 12:55
Adagene SG&A Expense (Quarterly)
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2020 | 2.866M |
| September 30, 2020 | 2.715M |
| Date | Value |
|---|---|
| December 31, 2019 | 1.170M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
1.170M
Minimum
Dec 2019
2.866M
Maximum
Dec 2020
2.250M
Average
2.715M
Median
Sep 2020
SG&A Expense (Quarterly) Benchmarks
| Sinovac Biotech Ltd | -- |
| CASI Pharmaceuticals Inc | 11.57M |
| Zai Lab Ltd | 82.63M |
| I-MAB | -- |
| Gracell Biotechnologies Inc (DELISTED) | 4.381M |